Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second-look laparotomy for ovarian carcinoma.

L J Copeland

    Clinical Obstetrics and Gynecology
    |December 1, 1985
    PubMed
    Summary

    Second-look laparotomy reliably assesses ovarian carcinoma chemotherapy status with minimal risk. Its prognostic value aids treatment decisions, though survival impact requires further study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).

    Gynecologic oncology·2023
    Same author

    Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.

    Gynecologic oncology·2013
    Same author

    Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer.

    Gynecologic oncology·2011
    Same author

    Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?

    Gynecologic oncology·2010
    Same author

    Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer.

    Gynecologic oncology·2009
    Same author

    Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer?

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007

    Area of Science:

    • Gynecologic Oncology
    • Surgical Oncology
    • Medical Oncology

    Background:

    • Ovarian carcinoma treatment often involves chemotherapy.
    • Assessing residual disease post-chemotherapy is crucial for patient management.
    • Second-look laparotomy is currently the most dependable method for disease evaluation.

    Purpose of the Study:

    • To evaluate the reliability and utility of second-look laparotomy in ovarian carcinoma patients post-chemotherapy.
    • To determine the prognostic significance of findings from second-look laparotomy.
    • To assess the potential for redirecting therapy based on second-look laparotomy results.

    Main Methods:

    • Retrospective analysis of patients undergoing second-look laparotomy after chemotherapy for ovarian carcinoma.
    • Evaluation of morbidity associated with the surgical procedure.
    • Correlation of surgical findings with patient prognosis and subsequent treatment adjustments.

    Main Results:

    • Second-look laparotomy is identified as the most reliable method for assessing disease status.
    • The procedure demonstrates minimal associated morbidity.
    • Findings from the surgery possess significant prognostic value and inform therapeutic strategies.

    Conclusions:

    • Second-look laparotomy is a valuable tool for evaluating ovarian carcinoma patients after chemotherapy.
    • While not definitively proven to impact survival due to lack of randomized trials, it offers crucial prognostic information.
    • The procedure aids in optimizing patient therapy by providing essential data on disease status.

    Related Experiment Videos